Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.
about
Regulation of Estrogen Receptor α by the SET7 Lysine MethyltransferaseRelationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancerPathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ.A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancerEvaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer.Evaluating the feasibility of performing window of opportunity trials in breast cancer.Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells.Role of traditional and new biomarkers in breast carcinogenesis.Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozole.Ki-67 biomarker in breast cancer of Indian womenEpithelial proliferation and hormone receptor status in the normal post-menopausal breast and the effects of hormone replacement therapy.Oestrogen receptor: a stable phenotype in breast cancerPharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancerThe omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility.Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries.Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancerBiological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast.Alteration of immunohistochemical biomarkers between pre- and post-chemotherapy: hormone receptors, HER2 and Ki-67.IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer.Attenuation of estrogen receptor alpha (ERalpha) signaling by selenium in breast cancer cells via downregulation of ERalpha gene expression.Oncogene products and other diagnostic markers in human breast cancer patients. Treatment effects and their significance.Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifen.Evaluation of Ki-67 and Bcl-2 antigen expression in breast carcinomas of women treated with raloxifene.Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancer.The effect of raloxifene on Bax protein expression in breast carcinomas of postmenopausal women.Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer.Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase cleavage and inhibiting nuclear factor kappa-B activity.Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer.Endocrine response and resistance in breast cancer: a role for the transcription factor Fos.Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy.Practical consensus recommendations regarding the management of hormone receptor positive early breast cancer in elderly women.
P2860
Q27650581-0E600158-AC64-4019-8373-668CDE456AA9Q28364208-C37665D0-0193-444C-BCEC-8992628C7823Q33494720-75A4D003-18FE-4FAF-BC49-E85135633878Q33739494-66023EB2-107B-4A75-A275-089A10D7CE25Q35012858-71CE6E0F-DB0A-4CD3-85D8-064410CB62D9Q35061474-F8BCDE48-4F6D-4E35-9DCC-B28629367BC5Q35230023-D9E4B1E3-46FD-4FA8-BA20-50AFBBB758D6Q35572905-A81D0590-506C-4641-A056-FFE5B10C9050Q35875007-0598F484-605A-4792-8976-6BBA31262293Q35913434-FC2C95F8-395C-417D-8EEC-C376E6C5C307Q36115441-AD2F3DB9-264C-4DCF-94D2-973D6A778F13Q36134377-0ED1734B-EED5-4CEA-A6F5-5C2BCDCDF31EQ36135542-D9F9E4E1-DF2F-4FD8-BE18-C4A5F04A16AFQ36166684-921C2836-8247-40CC-8F2D-349A2695D823Q36282791-A7E52BC8-42E0-4896-9CA2-C1B017752C17Q36431261-5E938107-52AE-4BE9-9880-A1BDEF3824E2Q36615792-A981DCB3-8DCC-490D-AF2D-7A2FC75D0A6DQ36670890-E7E4B291-D936-4B70-BEC1-1D1994A801A7Q37835106-5FB7DDA3-83BB-4A12-8312-00A63BF7D806Q38631164-BEE10DF2-631B-46BE-809C-EF2CD55F3F6AQ40374886-E074944B-72EF-4BAD-9937-B2094B5911F9Q40999436-5039C442-B153-4699-B258-C84D66A1E107Q42185179-22875B4E-1307-4620-A713-2FDA9BB3F96DQ43072014-4D37E97B-59E8-4410-A233-AFA8652E8ABFQ43549612-1748D7BE-B7EA-4872-A85A-AA744E8AD88FQ44278738-C273A739-EA01-4569-BEAB-BD2641E0598CQ44704125-1A5CCCBC-38C0-4E02-ADC3-82874CC0ADB9Q45018412-85F6B262-CEA0-4CAE-8182-6A9512677EEBQ45977374-C2E5438E-1B7E-447B-BE41-8A57A8832572Q48059912-BF76B61C-4A5A-479A-B8E0-3A390DC32ABEQ54105272-8D40BAE3-4A9A-45A6-8572-CDB6F01C09CDQ54400297-2F8D21C0-284B-4BB6-B671-44F954BF93DEQ55208842-69ADA447-B4E6-46D0-9DA4-481226B613C6
P2860
Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Effect of tamoxifen on Ki67 la ...... progesterone receptor status.
@ast
Effect of tamoxifen on Ki67 la ...... progesterone receptor status.
@en
type
label
Effect of tamoxifen on Ki67 la ...... progesterone receptor status.
@ast
Effect of tamoxifen on Ki67 la ...... progesterone receptor status.
@en
prefLabel
Effect of tamoxifen on Ki67 la ...... progesterone receptor status.
@ast
Effect of tamoxifen on Ki67 la ...... progesterone receptor status.
@en
P2093
P2860
P356
P1476
Effect of tamoxifen on Ki67 la ...... d progesterone receptor status
@en
P2093
E Anderson
I J Laidlaw
R B Clarke
P2860
P2888
P304
P356
10.1038/BJC.1993.111
P407
P577
1993-03-01T00:00:00Z